Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and Successes

导出原文传递

翻译打印收藏纠错

作者： Carcao, Manuel ^[1] ; Fukutake, Katsuyuki ^[2] ; Inbal, Aida ^[3] ; Kerlin, Bryce ^[4] ; Lassila, Riitta ^[5] ; Oldenburg, Johannes ^[6] ; Garly, May-Lill ^[7] ; Nugent, Diane ^[8]

作者单位： Novo Nordisk AS, Soborg, Denmark ^[1] Tokyo Med Univ, Dept Lab Med, Tokyo, Japan ^[2] Rabin Med Ctr, Thrombosis & Hemostasis Unit, Petah Tiqwa, Israel ^[3] Univ Toronto, Dept Paediat & Child Hlth Evaluat Sci, Hosp Sick Children, Div Haematol Oncol,Res ^[4] Helsinki Univ Hosp, Coagulat Disorders Unit, Hematol, Helsinki, Finland ^[5] UC Irvine Sch Med, Childrens Hosp Orange Cty, Orange, CA USA ^[6] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Columbus, OH 43210 USA ^[7] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany ^[8]

关键词 congenital FXIII deficiency recombinant factor XIII prophylaxis

发布时间 2017-12-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交